NEXENTIS TECHNOLOGIES INC. Basic Shares Outstanding (Weighted Average)
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Basic Shares Outstanding (Weighted Average) of 816.14 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 816.14K shares, a 701.22% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 612.72K shares, a 824.66% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.46M shares, a 670.76% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 943.27K shares, a 466.52% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2025 was 1.13M shares, a 505.03% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2024 was 187.22K shares, a 84.41% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.20M shares, a 127.05% increase from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2022 was 528.78K shares, a 77.43% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 816.14K shares 10-Q · filed 2026-08-13 | 714.99K shares 10-Q · filed 2026-08-13 | 1.30M shares derived: average of 3 quarters · filed 2026-08-13 | 1.21M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 612.72K shares 10-Q · filed 2026-05-14 | 1.54M shares derived: average of 2 quarters · filed 2026-05-14 | 1.34M shares derived: average of 3 quarters · filed 2026-05-14 | 1.03M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 2.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.70M shares derived: average of 2 quarters · filed 2026-03-31 | 1.17M shares derived: average of 3 quarters · filed 2026-08-13 | 1.13M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 943.27K shares 10-Q · filed 2025-11-13 | 522.57K shares derived: average of 2 quarters · filed 2026-08-13 | 689.73K shares 10-Q · filed 2025-11-13 | 357.70K shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 101.86K shares 10-Q · filed 2026-08-13 | 24.89M shares 10-Q · filed 2025-08-14 | 84.16K shares 10-Q · filed 2026-08-13 | 20.55M shares 10-Q · filed 2025-08-14 | 162.50K shares derived: average of 3 quarters · filed 2026-08-13 | 163.50K shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 66.26K shares 10-Q · filed 2026-05-14 | 16.17M shares 10-Q · filed 2025-05-15 | 192.82K shares derived: average of 2 quarters · filed 2026-05-14 | 184.05K shares derived: average of 3 quarters · filed 2026-05-14 | 990.26K shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | 319.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 242.94K shares derived: average of 2 quarters · filed 2026-03-31 | 1.30M shares derived: average of 3 quarters · filed 2026-03-31 | 187.22K shares 10-K · filed 2026-03-31 | 5.85M shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 166.50K shares 10-Q · filed 2025-11-13 | 5.82M shares 10-Q · filed 2024-11-14 | 1.79M shares derived: average of 2 quarters · filed 2025-11-13 | 143.16K shares 10-Q · filed 2025-11-13 | 4.07M shares 10-Q · filed 2024-11-14 | 2.07M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 3.41M shares 10-Q · filed 2025-08-14 | 3.18M shares 10-Q · filed 2025-08-14 | 2.70M shares derived: average of 3 quarters · filed 2025-08-14 | 2.36M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 2.96M shares 10-Q · filed 2025-05-15 | 2.35M shares derived: average of 2 quarters · filed 2025-05-15 | 2.01M shares derived: average of 3 quarters · filed 2025-05-15 | 1.77M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 1.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.54M shares derived: average of 2 quarters · filed 2025-03-31 | 1.37M shares derived: average of 3 quarters · filed 2025-03-31 | 1.20M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 1.33M shares 10-Q · filed 2024-11-14 | 1.18M shares derived: average of 2 quarters · filed 2024-11-14 | 1.02M shares 10-Q · filed 2024-11-14 | 935.05K shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 1.03M shares 10-Q · filed 2024-08-14 | 6.99M shares 10-Q · filed 2023-08-14 | 862.40K shares 10-Q · filed 2024-08-14 | 5.83M shares 10-Q · filed 2023-08-14 | 803.04K shares derived: average of 3 quarters · filed 2024-08-14 | 741.74K shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 695.93K shares 10-Q · filed 2024-05-15 | 4.67M shares 10-Q · filed 2023-05-15 | 691.04K shares derived: average of 2 quarters · filed 2024-05-15 | 646.64K shares derived: average of 3 quarters · filed 2024-05-15 | 1.20M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 686.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 621.99K shares derived: average of 2 quarters · filed 2024-04-01 | 1.37M shares derived: average of 3 quarters · filed 2024-04-01 | 528.78K shares 10-K · filed 2024-04-01 | 3.50M shares 10-K · filed 2023-03-27 | |||
| 2022-09-30 | 557.83K shares 10-Q · filed 2023-11-14 | 3.70M shares 10-Q · filed 2022-11-14 | 1.71M shares derived: average of 2 quarters · filed 2023-11-14 | 476.31K shares 10-Q · filed 2023-11-14 | 3.13M shares 10-Q · filed 2022-11-14 | 2.26M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 2.86M shares 10-Q · filed 2023-08-14 | 2.84M shares 10-Q · filed 2023-08-14 | 2.83M shares derived: average of 3 quarters · filed 2023-08-14 | 2.82M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 2.82M shares 10-Q · filed 2023-05-15 | 2.81M shares derived: average of 2 quarters · filed 2023-05-15 | 2.80M shares derived: average of 3 quarters · filed 2023-05-15 | 2.64M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 2.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 2.80M shares derived: average of 2 quarters · filed 2023-03-27 | 2.58M shares derived: average of 3 quarters · filed 2023-03-27 | 2.34M shares 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | 2.79M shares 10-Q · filed 2022-11-14 | 2.47M shares derived: average of 2 quarters · filed 2022-11-14 | 2.19M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 2.16M shares 10-Q · filed 2022-08-15 | 1.88M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 1.61M shares 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 1.52M shares 10-K · filed 2022-03-31 | |||||||
| 2019-12-31 | 1.42M shares 10-K · filed 2021-03-29 | 9.97M shares 10-K · filed 2020-03-30 | ||||||
| 2018-12-31 | 6.67M shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |